116 related articles for article (PubMed ID: 7955423)
1. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease.
Mann AC; Record CO; Self CH; Turner GA
Clin Chim Acta; 1994 Jun; 227(1-2):69-78. PubMed ID: 7955423
[TBL] [Abstract][Full Text] [Related]
2. Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer.
Thompson S; Dargan E; Turner GA
Cancer Lett; 1992 Sep; 66(1):43-8. PubMed ID: 1451094
[TBL] [Abstract][Full Text] [Related]
3. Haptoglobin. A potential reporter molecule for glycosylation changes in disease.
Turner GA
Adv Exp Med Biol; 1995; 376():231-8. PubMed ID: 8597253
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases.
Zhang S; Jiang K; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1021-9. PubMed ID: 24103369
[TBL] [Abstract][Full Text] [Related]
5. Abnormally fucosylated haptoglobin as a marker for alcoholic liver disease but not excessive alcohol consumption or non-alcoholic liver disease.
Chambers W; Thompson S; Skillen AW; Record CO; Turner GA
Clin Chim Acta; 1993 Oct; 219(1-2):177-82. PubMed ID: 8306457
[No Abstract] [Full Text] [Related]
6. The soluble mannose receptor (sMR) is elevated in alcoholic liver disease and associated with disease severity, portal hypertension, and mortality in cirrhosis patients.
Sandahl TD; Støy SH; Laursen TL; Rødgaard-Hansen S; Møller HJ; Møller S; Vilstrup H; Grønbæk H
PLoS One; 2017; 12(12):e0189345. PubMed ID: 29236785
[TBL] [Abstract][Full Text] [Related]
7. Lipid-bound sialic acid (LSA) in liver diseases of different etiologies.
Chrostek L; Cylwik B; Panasiuk A; Brodowska-Adamusiak D; Gruszewska E
Ann Hepatol; 2011; 10(2):150-4. PubMed ID: 21502676
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation of alpha-1-proteinase inhibitor and haptoglobin in ovarian cancer: evidence for two different mechanisms.
Turner GA; Goodarzi MT; Thompson S
Glycoconj J; 1995 Jun; 12(3):211-8. PubMed ID: 7496134
[TBL] [Abstract][Full Text] [Related]
9. Current Status of Alcoholic Liver Disease in Japan and Therapeutic Strategy.
Horie Y; Ebinuma H; Kikuchi M; Lamao Takanori
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Aug; 51(2):71-90. PubMed ID: 30462383
[TBL] [Abstract][Full Text] [Related]
10. Impact of elevation of total bilirubin level and etiology of the liver disease on serum N-glycosylation patterns in mice and humans.
Blomme B; Van Steenkiste C; Vanhuysse J; Colle I; Callewaert N; Van Vlierberghe H
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G615-24. PubMed ID: 20056895
[TBL] [Abstract][Full Text] [Related]
11. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
Mondal G; Saroha A; Bose PP; Chatterjee BP
Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
[TBL] [Abstract][Full Text] [Related]
12. A preliminary evaluation of the differences in the glycosylation of alpha-1-acid glycoprotein between individual liver diseases.
Anderson N; Pollacchi A; Hayes P; Therapondos G; Newsome P; Boyter A; Smith K
Biomed Chromatogr; 2002 Sep; 16(6):365-72. PubMed ID: 12228891
[TBL] [Abstract][Full Text] [Related]
13. Monosaccharide composition of haptoglobin purified from alcoholic cirrhotic and control sera determined by HPAE.
Mann AC; Thompson S; Record CO; Self CH; Turner GA
Biochem Soc Trans; 1993 May; 21(2):214S. PubMed ID: 8359464
[No Abstract] [Full Text] [Related]
14. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
15. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
16. Validity of carbohydrate-deficient transferrin (%CDT), gamma-glutamyltransferase (gamma-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers for chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin.
Hock B; Schwarz M; Domke I; Grunert VP; Wuertemberger M; Schiemann U; Horster S; Limmer C; Stecker G; Soyka M
Addiction; 2005 Oct; 100(10):1477-86. PubMed ID: 16185209
[TBL] [Abstract][Full Text] [Related]
17. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
[TBL] [Abstract][Full Text] [Related]
18. Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol.
Rua RM; Ojeda ML; Nogales F; Rubio JM; Romero-Gómez M; Funuyet J; Murillo ML; Carreras O
Life Sci; 2014 Jan; 94(2):158-63. PubMed ID: 24157457
[TBL] [Abstract][Full Text] [Related]
19. Marked 25-hydroxyvitamin D deficiency is associated with poor prognosis in patients with alcoholic liver disease.
Trépo E; Ouziel R; Pradat P; Momozawa Y; Quertinmont E; Gervy C; Gustot T; Degré D; Vercruysse V; Deltenre P; Verset L; Gulbis B; Franchimont D; Devière J; Lemmers A; Moreno C
J Hepatol; 2013 Aug; 59(2):344-50. PubMed ID: 23557869
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the CD14 genes are associated with susceptibility to alcoholic liver disease in Greek patients.
Nezi V; Deutsch M; Gazouli M; Alexopoulou A; Paparrigopoulos T; Liappas IA; Dourakis SP
Alcohol Clin Exp Res; 2013 Feb; 37(2):244-51. PubMed ID: 23009036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
